Makiko Mizutani

Bell Land General Hospital
Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Genomically determined subtypes and clinicopathological features as predictors of the efficacy of preoperative chemotherapy combined with HER2-targeted therapy for early-stage HER2-positive breast cancer.

Genomically determined subtypes and clinicopathological features as predictors of the efficacy of preoperative chemotherapy combined with HER2-targeted therapy for early-stage HER2-positive breast cancer.

Journal: BMC cancer

Published: June 12, 2025

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort.

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 09, 2021

Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.

Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.

Journal: Cancers

Published: May 31, 2021

Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case report.

Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case report.

Journal: Immunotherapy

Published: November 23, 2020

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.

Journal: Breast cancer research and treatment

Published: November 25, 2019

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Journal: Breast cancer (Tokyo, Japan)

Published: August 31, 2017

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

Journal: Chemotherapy

Published: January 31, 2017

A Case of Recurrent Breast Cancer with Adrenal Metastasis Resected Using Laparoscopic Surgery

A Case of Recurrent Breast Cancer with Adrenal Metastasis Resected Using Laparoscopic Surgery

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 31, 2017

Widespread subdural metastasis from breast cancer progressing rapidly with cerebral herniation: A case report.

Widespread subdural metastasis from breast cancer progressing rapidly with cerebral herniation: A case report.

Journal: Molecular and clinical oncology

Published: January 31, 2017

Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.

Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.

Journal: Human pathology

Published: July 29, 2016

Clinicopathological Factors Related to the Prognosis of Metastatic Breast Cancer Patients after Development of Brain Metastasis.

Clinicopathological Factors Related to the Prognosis of Metastatic Breast Cancer Patients after Development of Brain Metastasis.

Journal: Breast care (Basel, Switzerland)

Published: March 19, 2016

Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer

Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 02, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026